Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munir Alam

Showing results (141-150 of 206) with videos related to

Pageof 21
Sort By:
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.
Science Translational Medicine|April 29, 2016
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesRuijun Zhang, Laurent Verkoczy, Kevin Wiehe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan MetabolismTodd Bradley, Guang Yang, Olga Ilkayeva, et al.
Cell|July 29, 2014
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodiesFeng Gao, Mattia Bonsignori, Hua-Xin Liao, et al.
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.
Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V<sub>H</sub>1-2-rearranging mouse modelsHimanshu Batra, Sai Luo, Kevin O Saunders, et al.
Plos Pathogens|September 19, 2019
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Pageof 21

Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.
Frontiers in Big Data|July 2, 2021
Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection TrialsWilliam Chad Young, Lindsay N Carpp, Sidhartha Chaudhury, et al.
Science Translational Medicine|April 29, 2016
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesRuijun Zhang, Laurent Verkoczy, Kevin Wiehe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan MetabolismTodd Bradley, Guang Yang, Olga Ilkayeva, et al.
Cell|July 29, 2014
Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodiesFeng Gao, Mattia Bonsignori, Hua-Xin Liao, et al.
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.
Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V<sub>H</sub>1-2-rearranging mouse modelsHimanshu Batra, Sai Luo, Kevin O Saunders, et al.
Plos Pathogens|September 19, 2019
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Pageof 21